Literature DB >> 18689700

Authenticating cell lines in ophthalmic research laboratories.

Robert Folberg1, Shrihari S Kadkol, Shahar Frenkel, Klara Valyi-Nagy, Martine J Jager, Jacob Pe'er, Andrew J Maniotis.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18689700      PMCID： PMC2576485          DOI： 10.1167/iovs.08-2324

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN： 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  45 in total

1.  The RAS-BRAF kinase pathway is not involved in uveal melanoma.

Authors:  Emine Kiliç; Hennie T Brüggenwirth; Michael M P J Verbiest; Ellen C Zwarthoff; Neeltje M Mooy; Gre P M Luyten; Annelies de Klein
Journal:  Melanoma Res       Date:  2004-06       Impact factor: 3.599

2.  Adoptive T cell immunotherapy of human uveal melanoma targeting gp100.

Authors:  R P Sutmuller; L R Schurmans; L M van Duivenvoorde; J A Tine; E I van Der Voort; R E Toes; C J Melief; M J Jager; R Offringa
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

3.  Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.

Authors:  Charlotta All-Ericsson; Leonard Girnita; Stefan Seregard; Armando Bartolazzi; Martine J Jager; Olle Larsson
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-01       Impact factor: 4.799

4.  Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix.

Authors:  Andrew J Maniotis; Xue Chen; Christopher Garcia; Phillip J DeChristopher; Ding Wu; Jacob Pe'er; Robert Folberg
Journal:  Lab Invest       Date:  2002-08       Impact factor: 5.662

5.  An orthotopic model for human uveal melanoma in SCID mice.

Authors:  Arthur J Mueller; Andrew J Maniotis; William R Freeman; Dirk-Uwe Bartsch; Ulrich C Schaller; Germaine Bergeron-Lynn; Lingyun Cheng; Ibrahim Taskintuna; Xue Chen; June Kan-Mitchell; Robert Folberg
Journal:  Microvasc Res       Date:  2002-09       Impact factor: 3.514

6.  Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway.

Authors:  Armelle Calipel; Gaelle Lefevre; Celio Pouponnot; Frédéric Mouriaux; Alain Eychène; Frédéric Mascarelli
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

7.  BRAF mutations in conjunctival melanoma.

Authors:  Heather Gear; Hawys Williams; Ewan G Kemp; Fiona Roberts
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

8.  Morphology and behavior of primary ocular melanomas in 91 dogs.

Authors:  B P Wilcock; R L Peiffer
Journal:  Vet Pathol       Date:  1986-07       Impact factor: 2.221

9.  Molecular determinants of human uveal melanoma invasion and metastasis.

Authors:  Elisabeth A Seftor; Paul S Meltzer; Dawn A Kirschmann; Jacob Pe'er; Andrew J Maniotis; Jeffrey M Trent; Robert Folberg; Mary J C Hendrix
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

10.  Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas.

Authors:  S C Edmunds; I A Cree; F Dí Nícolantonío; J L Hungerford; J S Hurren; D P Kelsell
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640
View more
  31 in total

1.  Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma.

Authors:  Pierre L Triozzi; Wayne Aldrich; Arun Singh
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-25       Impact factor: 4.799

2.  Modeling human choroidal melanoma xenograft growth in immunocompromised rodents to assess treatment efficacy.

Authors:  Rod D Braun; Kerry S Vistisen
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

3.  Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.

Authors:  Joseph C Manarang; Deborah C Otteson; Alison M McDermott
Journal:  Curr Eye Res       Date:  2017-09-14       Impact factor: 2.424

4.  Tight junction-associated signaling pathways modulate cell proliferation in uveal melanoma.

Authors:  Ashwath Jayagopal; Jin-Long Yang; Frederick R Haselton; Min S Chang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-01       Impact factor: 4.799

Review 5.  Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis).

Authors:  Martine J Jager; J Antonio Bermudez Magner; Bruce R Ksander; Sander R Dubovy
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

Review 6.  Culturing Uveal Melanoma Cells.

Authors:  Martina Angi; Mieke Versluis; Helen Kalirai
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

7.  Short Tandem Repeat (STR) Profiles of Commonly Used Human Ocular Surface Cell Lines.

Authors:  Alison M McDermott; Hasna Baidouri; Ashley M Woodward; Wendy R Kam; Yang Liu; Xiaomin Chen; Jillian F Ziemanski; Kerry Vistisen; Linda D Hazlett; Kelly K Nichols; Pablo Argüeso; David A Sullivan
Journal:  Curr Eye Res       Date:  2018-06-04       Impact factor: 2.424

8.  Genetic and molecular characterization of uveal melanoma cell lines.

Authors:  K G Griewank; X Yu; J Khalili; M M Sozen; K Stempke-Hale; C Bernatchez; S Wardell; B C Bastian; S E Woodman
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-02       Impact factor: 4.693

9.  Notch signaling promotes growth and invasion in uveal melanoma.

Authors:  Laura Asnaghi; Katayoon B Ebrahimi; Karisa C Schreck; Eli E Bar; Michael L Coonfield; W Robert Bell; James Handa; Shannath L Merbs; J William Harbour; Charles G Eberhart
Journal:  Clin Cancer Res       Date:  2012-01-06       Impact factor: 12.531

10.  Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma.

Authors:  Armelle Calipel; Solange Landreville; Arnaud De La Fouchardière; Frédéric Mascarelli; Michel Rivoire; Nicolas Penel; Frédéric Mouriaux
Journal:  Clin Exp Metastasis       Date:  2014-03-21       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.